Andrea Johnston, MD

Oklahoma University
Oklahoma City, Oklahoma, United States

Presentation(s):

• Paper 67 - NRG-DT001 PHASE IB TRIAL OF NEOADJUVANT NAVTEMADLIN AND RADIOTHERAPY IN TP53 WILD-TYPE SOFT TISSUE SARCOMA: PRELIMINARY EFFICACY ANALYSIS

  Saturday, November 15, 2025
  11:00 AM - 12:00 PM EST

  Disclosure information not submitted.